跳转至内容
Merck
CN

A9883

N-(2-乙酰氨基)-亚氨基二乙酸

≥98% (titration)

别名:

N-(2-乙酰氨基)-亚氨基二乙酸, N-(氨基甲酰甲基)亚氨基二乙酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
H2NCOCH2N(CH2CO2H)2
化学文摘社编号:
分子量:
190.15
UNSPSC Code:
12161700
NACRES:
NA.25
PubChem Substance ID:
EC Number:
247-530-0
Beilstein/REAXYS Number:
1787181
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥98% (titration)

form

powder

pH

1.5-3.0

useful pH range

6.0-7.2

pKa (25 °C)

6.6

mp

219 °C (dec.) (lit.)

solubility

1 M NaOH: 160 mg/mL, clear, colorless

application(s)

diagnostic assay manufacturing

storage temp.

room temp

SMILES string

NC(=O)CN(CC(O)=O)CC(O)=O

InChI

1S/C6H10N2O5/c7-4(9)1-8(2-5(10)11)3-6(12)13/h1-3H2,(H2,7,9)(H,10,11)(H,12,13)

InChI key

QZTKDVCDBIDYMD-UHFFFAOYSA-N

General description

ADA是一种可用于生物化学和分子生物学的两性离子缓冲剂。它是在1960′年代开发的Good缓冲液之一,可为广泛的生化研究应用提供6.15 - 8.35的pH缓冲范围。Good及其同事在其开创性的报道中对ADA的合成及物理性质进行了描述。ADA缓冲液在水溶液中的可用范围是6.0 - 7.2。

Application

含氢氧化钠和氯化钠(pH 5.67-7.57,有效pH范围6.4-7.4)的生物缓冲液组分。用于制备固相pH梯度。

Preparation Note

该产品可溶于1 M NaOH(160mg/mL),产生澄清无色的溶液。


Still not finding the right product?


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

Product Information Sheet


Hydrogen ion buffers for biological research
Good NE, et al.
Biochemistry, 5( (2), 467-477 (1966)
Harold Bays et al.
The Journal of clinical endocrinology and metabolism, 100(8), 3140-3148 (2015-06-02)
Despite current standard of care, many patients at high risk of cardiovascular disease (CVD) still have elevated low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is a fully human monoclonal antibody inhibitor of proprotein convertase subtilisin/kexin type 9. The objective of the
Johannan F Brandse et al.
Journal of Crohn's & colitis, 9(11), 973-981 (2015-06-28)
High serum concentrations of infliximab [IFX] and adalimumab [ADA] may be associated with adverse effects in patients with inflammatory bowel disease [IBD]. We aimed to investigate whether high anti-tumour necrosis factor [TNF] trough levels [TLs] were associated with toxicity and



全球贸易项目编号

货号GTIN
A9883-250G04061832546506
A9883-100G04061832546490
A9883-25G04061833412626
A9883-1KG04061835265183